Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

128.42
Delayed Data
As of 3:59pm ET
 -1.47 / -1.13%
Today’s Change
67.81
Today|||52-Week Range
131.16
+42.25%
Year-to-Date
ABIOMED Raised to Strong Buy: Should You Add the Stock?
11:03am / Zacks.com - Paid Partner Content
Patterson Companies Faces Multiple Issues: Dump Now?
Sep 26 / Zacks.com - Paid Partner Content
Abiomed: Heart Pumps Receive Regulatory Approval in Japan
Sep 28 / Zacks.com - Paid Partner Content
CryoLife Hits a 52-Week High on Strong Growth Prospects
Sep 23 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for September 28th
Sep 28 / Zacks.com - Paid Partner Content
Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Sep 20 / Zacks.com - Paid Partner Content
Nevro Hits New 52-Week High on Solid HF10 Therapy Sales
Sep 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close129.89
Today’s open130.27
Day’s range126.18 - 131.16
Volume483,443
Average volume (3 months)509,514
Market cap$5.6B
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+37.91%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio136.6
Price/Sales12.92
Price/Book15.00

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-1.02-1.36%
TFXTeleflex Inc-3.51-2.09%
DXCMDexCom Inc-1.94-2.16%
NUVANuVasive Inc-1.56-2.32%
Data as of 4:02pm ET, 09/29/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Search for Jobs